GARDASIL 9 INJ HPV Vaccine 9-26yrs. 10x0.5mL PFS/Box

Key Features:

1. Comprehensive HPV Protection: GARDASIL® 9 is formulated to protect against nine HPV types: 6, 11, 16, 18, 31, 33, 45, 52, and 58. These types are responsible for the majority of HPV-related cancers and diseases, including cervical, vulvar, vaginal, anal cancers, and genital warts.
2. Indicated for Ages 9-26: The vaccine is approved for use in individuals aged 9 through 26 years. It is most effective when administered before exposure to HPV through sexual contact, making it ideal for pre-teens and young adults.
3. Prevention of Multiple Cancers: GARDASIL® 9 helps prevent cervical cancer in females, as well as vulvar, vaginal, and anal cancers in both males and females. It also prevents precancerous lesions and genital warts caused by the covered HPV types.
4. Prefilled Syringes for Convenience: Each box contains 10 prefilled syringes (0.5mL each), simplifying the vaccination process. The prefilled syringes ensure accurate dosing and are ready to use, reducing preparation time and enhancing safety.
5. Proven Efficacy: Clinical trials have demonstrated the high efficacy of GARDASIL® 9 in preventing infections and diseases caused by the nine HPV types included in the vaccine. It offers extended protection compared to earlier HPV vaccines.
6. Recommended Vaccination Schedule: GARDASIL® 9 is administered in a series of either two or three doses, depending on the age at initial vaccination:
   • Ages 9-14: Two-dose schedule (0 and 6-12 months)
   • Ages 15-26: Three-dose schedule (0, 2, and 6 months) Following the recommended schedule ensures optimal protection.
7. Safe and Well-Tolerated: The vaccine has been thoroughly tested for safety and is generally well-tolerated. Common side effects include pain at the injection site, swelling, redness, and mild fever, which are typical of most vaccines.
8. WHO and CDC Recommendations: GARDASIL® 9 is recommended by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) as part of routine immunization programs for adolescents and young adults.
9. Storage and Handling: The vaccine should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F) and should not be frozen. Proper storage ensures the vaccine’s effectiveness and safety.
10. Trusted Manufacturer: GARDASIL® 9 is produced by Merck, a leader in vaccine development and manufacturing. The company’s commitment to quality and safety ensures that you are receiving a reliable and effective vaccine.

Protect against HPV-related diseases and cancers with GARDASIL® 9. With its broad coverage, proven efficacy, and convenient prefilled syringes, this vaccine is a critical tool in preventive healthcare for individuals aged 9 to 26 years. Ensure your patients receive comprehensive protection with GARDASIL® 9.